CTTH - CTT Pharma Files 2 USA Patents and 2 Canadian Patents
(TheNewswire)
Tampa, Florida, United States – TheNewswire – October 12, 2022 – CTT Pharmaceutical Holdings, Inc.(OTC:CTTH) is pleased to announce that we have filed four new patents,two in the USA and two in Canada. These new patents offerNaturally-derived Wafer Formulations containing Analgesics and Microemulsions . The strengthened and updatedintellectual property focuses on wafer compositions incorporating anaturally-derived and unique type of nanoparticles loaded withanalgesics. This naturally-derived technology is not limited toanalgesics, but can also incorporate other Active PharmaceuticalIngredients(APIs), Natural Health Ingredients(NHIs) and psychoactivecompounds. Examples being, Nicotine, CBD, Cannabinoids, and Psilocybinto name a few.
Ryan Khouri, CEO of CTT Pharma statedthat these patents will continue to strengthen and protect ourtechnology in multiple ways. Including but not limited to a two stageabsorption process and allowing for the taste from our dissolvablestrips to last longer after the strip has dissolved. Mr. Khourifurther states that, I’m excited that these newly filed patents willoffer stronger and better layers of protection to our existingpatents. We worked very hard on these newly filed patents and willcontinue to do the necessary research and development for thisadvancement in our technology. These additional patents would give CTT5 Canadian Patents and 4 US Patents.
CTT will continue to updateshareholders as more news becomes available.
www.cttpharmaceuticals.com
www.linkedin.com/in/ryan-khouri-679a251b7
Ryan Khouri at 813-606-0060
Copyright (c) 2022 TheNewswire - All rights reserved.